Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon

Politico: Biden to toss Trump’s ‘conscience’ rule for healthcare workers

The Biden administration is making a move to get rid of a rule that allows healthcare workers to refuse to provide services that go against their personal beliefs. 

Leslee Shaw, PhD, and former presidents of both SCCT and ASNC discusses the role of CT and FFR-CT in the 2021 chest pain guidelines.

VIDEO: Cardiac CT now recommended as a front-line chest pain assessment tool

Leslee Shaw, PhD, director of the Blavatnik Family Women’s Health Research Institute at Mount Sinai Hospital in New York and former president of the Society of Cardiovascular Computed Tomography (SCCT) and the American Society of Nuclear Cardiology (ASNC), explains the role of cardiac computed tomography (CT) in the recent 2021 chest pain guidelines.

Thumbnail

7 reasons clinicians are leaving jobs in the era of the great resignation

Two years into the pandemic, healthcare organizations in the U.S. are dealing with major staffing shortages. Here are some of the top reasons why clinicians leave their jobs.

The ASNC is one of several medical imaging societies asking Congress to repeal the appropriate use criteria (AUC) criteria mandate. They say it poses issues for clinicians and is becoming outdated by changes in CMS payment systems. The AUC requirements call for documentation using CVMS authorized software in order to show advanced imaging such as nuclear and CT is justified, or else Medicare payments might be withheld.

American Society of Nuclear Cardiology urges Congress to speed prior authorizations, repeal AUC mandate 

Over the past few weeks, members of ASNC’s Health Policy Committee have held meetings with their members of Congress.

covid-19 money virus coronavirus dollar

American Heart Association awards $10.6M to researchers investigating the long-term cardiovascular effects of COVID-19

The grants went to 11 different research teams in the United States and are expected to fund these projects for three years.

Computer

Significant disparities exist in utilization of self-scheduling radiology exams, research shows

Researchers revealed that less than 1% of more than 46,000 patients took advantage of online self-scheduling tools.

Cardiology’s average salary climbs to $490k, No. 3 among all specialties

This continues a consistent rise in pay for the specialty—the same report recorded cardiology’s average salary as $459,000 in 2021, $438,000 in 2020 and $430,000 in 2019.

Thumbnail

AI boosts performance of novice nurses when assessing pregnant patients via ultrasound

Using a handheld probe and smartphone, nurse midwives were able to estimate gestational age as accurately as certified sonographers.


 

Displaying 1473 - 1480 of 6646

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup